Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3.
about
N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort StudyLung function in very preterm infants with patent ductus arteriosus under conservative management: an observational studyOutcomes of Early Ligation of Patent Ductus Arteriosus in Preterms, Multicenter Experience.Urinary Neutrophil Gelatinase-associated Lipocalin in the evaluation of Patent Ductus Arteriosus and AKI in Very Preterm Neonates: a cohort study.Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications.Adjunctive drug therapies for treatment of respiratory diseases in the newborn: based on evidence or habit?Morbidities associated with patent ductus arteriosus in preterm infants. Nationwide cohort study.Association between early echocardiography, therapy for patent ductus arteriosus, and outcomes in very low birth weight infants.Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants.Percutaneous closure of a large patent ductus arteriosus in a preterm newborn weighing 1400 g without using arterial sheath: an innovative technique.Tissue-type plasminogen activator contributes to remodeling of the rat ductus arteriosus.Percutaneous PDA Closure in Extremely Low Birth Weight Babies.Intraoperative High-Frequency Jet Ventilation Is Equivalent to Conventional Ventilation During Patent Ductus Arteriosus Ligation.Divergent risk factors for cerebellar and intraventricular hemorrhage.Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus.Hospital volume and mortality due to preterm patent ductus arteriosus.Recent advances in cardiac catheterization for congenital heart disease.Cerebral oxygen saturation and peripheral perfusion in the extremely premature infant with intraventricular and/or pulmonary haemorrhage early in life.Using benchmarking to identify inter-centre differences in persistent ductus arteriosus treatment: can we improve outcome?Effects of prophylactic oral ibuprofen on the closure rate of patent ductus arteriosus in premature infants
P2860
Q35801673-11CB102D-8196-48FD-8E24-0A23262D4257Q35819433-8FC89249-636D-4F39-9EF1-3DA96468D770Q35857832-C6A979A0-FD5C-4BFA-BD27-B98C617E16DBQ36244640-F31BF027-99E7-4944-8C2F-A785497A02C3Q36714131-4CD6475C-8470-47F4-B1CD-20CEAAA8697BQ38199558-8B3783D6-4344-4BF7-BDDF-E5B1FF8DCCA0Q38708503-D70273F5-E5F2-4A42-8CF8-37187131E54FQ38720682-5B8044DD-D6DF-4AD4-A1DD-2A0A6149F077Q38843760-66DD8DBA-9BB7-447A-9376-A0C120ADC530Q39416886-799E8FB3-6393-4FB7-94F8-DD55C6B55B08Q47221674-4CDFAF15-D305-4CD3-9EFC-B1A3F9AE18B8Q47229917-BDAB8485-B295-4649-BC72-85B52FD99D40Q47260017-BC0BBB92-B8A1-43A3-A34E-03D3090B5168Q47271462-72F17058-F7FB-471E-A9AB-6868D9C1F8E2Q47915221-1BD21151-D840-45FF-9EAC-44ADE3AEFEB2Q48119321-E51F699C-F3D0-444E-8BEC-4E3D7EB88DB9Q51305860-19AE5EDD-CB6B-4F7D-BE36-AB40F8B74C04Q52325660-F68AD9F6-77B1-4ADD-9252-380316195450Q52562829-E3F21C10-0E34-43BE-A2C4-4EE640D6080FQ52684141-C5578A53-93ED-458F-8E5E-AC4303CCDF26Q58739837-D3C78C56-9AA0-46CE-AE27-AF2457E490C3
P2860
Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3.
@en
Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3.
@nl
type
label
Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3.
@en
Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3.
@nl
prefLabel
Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3.
@en
Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3.
@nl
P2093
P50
P1476
Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3
@en
P2093
Anna Sellmer
Bente Høst
Jesper Vandborg Bjerre
Michael Rahbek Schmidt
Tine Brink Henriksen
P304
P356
10.1136/ARCHDISCHILD-2013-303816
P577
2013-07-26T00:00:00Z